Mark G. Foletta, serving as a director at AMN Healthcare Services Inc. (NASDAQ: AMN), has completed the sale of 3,681 shares of the company's common stock. The transactions were finalized on June 15, 2026, resulting in a total realized value of $114,361. The execution of these sales occurred within a specific price band, with individual share prices ranging from $30.82 to $31.22. This insider divestment takes place while AMN Healthcare's stock is trading in close proximity to its 52-week high of $32.52. Over the preceding six-month period, the stock has experienced a significant appreciation, surging by 96%.
According to analysis provided by InvestingPro, AMN Healthcare's current valuation remains undervalued relative to certain metrics, suggesting potential for further upside despite the recent rally. The company is currently listed on InvestingPro's roster of Most Undervalued stocks. The insider sales were structured through two distinct transactions. The initial transaction involved the disposition of 1,681 shares at a weighted average price of $31.067 per share. Within this block, individual sales occurred between $30.86 and $31.22. The subsequent transaction involved the sale of 2,000 shares at a weighted average price of $31.069 per share, with individual sales occurring between $30.82 and $31.22. Both transactions were executed pursuant to a Rule 10b5-1 trading plan that Mr. Foletta adopted on March 12, 2026.
All shares sold were held indirectly through The Foletta Family Trust DTD 1/30/2015. Mr. Foletta serves as a trustee for this entity. Following the completion of these sales, Mr. Foletta, via the trust, retains a position of 17,917 shares of AMN Healthcare common stock. The timing of this insider transaction coincides with a period of strong operational performance for the company. AMN Healthcare reported financial results for the first quarter of 2026 that surpassed market expectations. The company achieved an earnings per share (EPS) of $2.10. This figure significantly exceeded the forecasted $1.62, marking a 29.63% surprise. Revenue also outperformed forecasts, reaching $1.38 billion compared to the anticipated $1.23 billion, representing a 12.2% exceedance.
In parallel with the financial reporting, AMN Healthcare announced several key leadership appointments. Kristy Willis has been appointed as Chief Commercial Officer. Holly Novak has been named Chief People Officer. Additionally, the company added Eric Palmer to its board of directors, effective May 1, 2026. Palmer brings extensive experience from previous roles, including serving as CEO of Evernorth Health Services. Broader market indicators also reflect activity in the sector. Jefferies reported a 3.6% week-over-week increase in demand for temporary nursing staff, highlighting a growing trend in the healthcare staffing market. AMN Healthcare Services is currently trading at $31.88, reflecting a +1.00 (+3.24%) change. Pre-market data shows a price of $31.98, reflecting a +0.10 (+0.31%) change as of 05:29:06.